当前位置:首页 - 行情中心 - 众生药业(002317) - 财务分析

众生药业

(002317)

  

流通市值:160.02亿  总市值:178.57亿
流通股本:7.62亿   总股本:8.50亿

众生药业(002317)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.85亿元,每股收益0.22元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益404634.02万元,未分配利润93299.74万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产515599.32万元,负债110965.30万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,299,729,912.96634,261,440.112,467,418,394.641,908,022,039.84
营业总成本1,094,636,663.42546,759,207.072,228,489,469.541,701,672,490.4
其他经营收益
营业利润216,556,670.4499,306,076.35-279,951,942.91236,330,273.87
利润总额215,745,146.8299,262,271.07-335,881,686.5177,722,833.51
净利润184,821,629.2981,448,217.01-373,963,482.1135,910,863.59
每股收益
其他综合收益-5,337,076.39-2,834,799.65-2,507,517.14-448,465.64
综合收益总额179,484,552.978,613,417.36-376,470,999.24135,462,397.95
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,121,150,116.383,142,454,645.153,462,803,674.13,260,603,051.47
非流动资产:
非流动资产合计2,034,843,052.882,090,320,679.942,090,689,559.172,559,443,395.74
资产总计5,155,993,169.265,232,775,325.095,553,493,233.275,820,046,447.21
流动负债:
流动负债合计880,853,895.08801,083,105.931,203,478,158.39418,331,904.53
非流动负债:
非流动负债合计228,799,120.57337,678,830.16339,900,665.87858,550,645.69
负债合计1,109,653,015.651,138,761,936.091,543,378,824.261,276,882,550.22
所有者权益(或股东权益):
归属于母公司股东权益合计3,948,476,094.873,994,494,570.993,914,773,066.254,385,722,586.9
股东权益合计4,046,340,153.614,094,013,3894,010,114,409.014,543,163,896.99
负债和股东权益合计5,155,993,169.265,232,775,325.095,553,493,233.275,820,046,447.21
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,040,028,993.65412,758,125.622,496,935,093.691,912,197,257.31
经营活动现金流出小计1,000,364,730.08441,373,093.532,159,092,831.651,611,736,855.38
经营活动产生的现金流量净额39,664,263.57-28,614,967.91337,842,262.04300,460,401.93
投资活动产生的现金流量:
投资活动现金流入小计662,322,660.22312,493,075.661,593,659,455.391,116,898,539.09
投资活动现金流出小计541,987,535.92294,451,808.321,208,990,628.99996,274,365.01
投资活动产生的现金流量净额120,335,124.318,041,267.34384,668,826.4120,624,174.08
筹资活动产生的现金流量:
筹资活动现金流入小计257,025,568.5949,094,807.63342,869,171.6841,738,492.28
筹资活动现金流出小计793,271,961.85446,652,662.39905,040,988.81904,216,153.42
筹资活动产生的现金流量净额-536,246,393.26-397,557,854.76-562,171,817.13-862,477,661.14
汇率变动对现金及现金等价物的影响-5,718.22-1,963.5920,330.75-14,399.8
现金及现金等价物净增加额-376,252,723.61-408,133,518.92160,359,602.06-441,407,484.93
期末现金及现金等价物余额985,831,838.39953,951,043.081,362,084,562760,317,475.01
补充资料:
现金及现金等价物的净增加额-376,252,723.61-160,359,602.06-
最新报告期:2025-08-11
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国盛证券张金洋,胡偌碧0.410.510.602025-08-11
华鑫证券胡博新0.390.490.602025-07-16
TOP↑